Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.530
+0.040 (1.61%)
At close: Oct 8, 2025, 4:00 PM EDT
2.580
+0.050 (1.98%)
After-hours: Oct 8, 2025, 7:12 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.70 million as of October 8, 2025. Its market cap has increased by 32.38% in one year.
Market Cap
8.70M
Enterprise Value
2.81M
1-Year Change
32.38%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.70M, a decrease of -99.24%. That is a compound annual growth rate of -67.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 8.57M | 35.91% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 762.82B |
| Johnson & Johnson | 455.18B |
| AbbVie | 407.32B |
| UnitedHealth Group | 337.18B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.71B |